© PR Newswire
10.06.2024
INDV
LISTED
NASDAQ
Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder
News Preview
Double-blind, placebo-controlled study aims to measure safety and efficacy of INDV-2000 over 3 months in participants with moderate to severe Opioid Use Disorder.INDV-2000 is an investigational non-opioid treatment that acts through the orexin pathway, shown to play a key role in the neurobiology of substance use disorder in animals.Recent animal...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.06.2024
EVT
LISTED
XETR
Results of the Annual General Meeting 2024
News Preview
Most agenda items adopted with great majority
Annual General Meeting 2024 elects Dr Duncan McHale and Wesley Wheeler to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka
Hamburg, Germany, 10 June 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.06.2024
EVT
LISTED
XETR
Ergebnisse der Hauptversammlung 2024
News Preview
Die meisten Tagesordnungspunkte mit großer Mehrheit beschlossen
Hauptversammlung 2024 wählt Dr. Duncan McHale und Wesley Wheeler in den Aufsichtsrat; Dr. Elaine Sullivan und Dr. Mario Polywka scheiden aus dem Aufsichtsrat aus
Hamburg, 10. Juni 2024:
Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; ......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
10.06.2024
ATNM
LISTED
XASE
Actinium Highlights Mutation Data from the Phase 3 SIERRA Trial of Iomab-B and Novel Linker Technology to Support Solid Tumor Antibody Radiation Conjugate Development at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
News Preview
Iomab-B led bone marrow transplant improved survival in patients with high-risk relapsed or refractory acute myeloid leukemia including those with a TP53 mutationIomab-B safely delivered radiation to the target bone marrow at greater amounts than achievable with total body irradiation while sparing healthy non-target organs and enabled 100% acces...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
10.06.2024
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.06.2024
ILM1
LISTED
XETR
Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
News Preview
Press Release
Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
Berlin, June 7, 2024 – Hauck & Aufhäuser Investment Banking initiated coverage of Medios AG yesterday and recommended the shares as a “buy”. The price target is €23.00 and thus around 55 percent above the Xetra closing price on ......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.06.2024
ILM1
LISTED
XETR
Hauck & Aufhäuser startet Coverage der Medios AG mit Kaufempfehlung und Kursziel von 23,00 €
News Preview
Pressemitteilung
Hauck & Aufhäuser startet Coverage der Medios AG mit Kaufempfehlung und Kursziel von 23,00 €
Berlin, 7. Juni 2024 – Hauck & Aufhäuser Investment Banking hat gestern die Coverage der Medios AG aufgenommen und die Aktien zum Kauf („Buy“) empfohlen. Das Kursziel liegt bei 23,00 € und damit rund 55 Prozent über dem Xetra-Schl......
Themefolio
Profiler
Peergroup
© Globe Newswire
07.06.2024
ZEAL
LISTED
CPH
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
News Preview
Company announcement - No. 30 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
EAPI
LISTED
EURONEXT
Market update : FOCUS-27 transformation project financing
News Preview
Press release...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
News Preview
CONSHOHOCKEN, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced results from new analyses of the Phase 3 MAESTRO-NASH trial of Rezdiffra being presented at the EASL Congress, which takes...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.06.2024
ILM1
LISTED
XETR
Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
News Preview
Press release
Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
Berlin, June 06, 2024 – Medios, a leading provider of Specialty Pharma in Europe, has completed the acquisition of Ceban Pharmaceuticals B.V. (“Ceban”), a fast-growing, leading pharmaceutical compounding platform with operati......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.06.2024
ILM1
LISTED
XETR
Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
News Preview
Press release
Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
Berlin, June 06, 2024 – Medios, a leading provider of Specialty Pharma in Europe, has completed the acquisition of Ceban Pharmaceuticals B.V. (“Ceban”), a fast-growing, leading pharmaceutical compounding platform with operati......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
06.06.2024
ILM1
LISTED
XETR
Medios AG schließt Übernahme von Ceban erfolgreich ab und baut damit Marktposition in Europa deutlich aus
News Preview
Pressemitteilung
Medios AG schließt Übernahme von Ceban erfolgreich ab und baut damit Marktposition in Europa deutlich aus
Berlin, 06. Juni 2024 – Medios, ein führender Anbieter von Specialty Pharma in Europa, hat die Übernahme von Ceban Pharmaceuticals B.V. („Ceban“), eine schnell wachsende, führende pharmazeutische Compounding-Plattform mit Tä......
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
NSIS B
LISTED
CPH
Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
EAPI
LISTED
EURONEXT
EUROAPI reaches major Health IPCEI milestone with official notification from European Commission
News Preview
Paris – June 6, 2024 – EUROAPI has received official notification from the European Commission that the Company has been selected as one of the 13 companies eligible to share up to EUR 1 billion in total public funding under the Important Project of Common European Interest (IPCEI) dedicated to the pharmaceutical sector, “IPCEI Med4Cure”....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
MURA
LISTED
NASDAQ
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
News Preview
WALTHAM, Mass. and DUBLIN, June 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that Caroline Loew, Ph.D., CEO, will present at the...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
QGEN
LISTED
NYSE
QIAGEN führt Assay-Design-Tool für digitale PCR Plattform QIAcuity ein und erweitert Anpassungsmöglichkeiten in Forschungsplattform GeneGlobe
News Preview
Neues Custom Assay Design Tool für digitale PCR-Plattform QIAcuity zur Anylayse von Kopienzahlvariationen unterstützt individuelle Bedürfnisse von Forschern und ergänzt QIAGENs bestehende vorgefertigte Assays // GeneGlobe Design- und Analyse-Hub erhält weitere Funktionen zur Verbesserung der Benutzerfreundlichkeit und gemeinsamen Erstellung von Pan...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
News Preview
CONSHOHOCKEN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024, and will present at 8:40 A.M. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
OSE
LISTED
EURONEXT
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant
News Preview
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2024
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2024
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
News Preview
MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Med...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2024
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2024
HLN
LISTED
LSE
Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition
News Preview
BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (LSE / NYSE: HLN). This trans...
Themefolio
Profiler
Peergroup
© Newsfile
03.06.2024
COPN
LISTED
SIX
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX
News Preview
Dublin, Ireland--(Newsfile Corp. - June 3, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) with its Cosmo Intelligent Medical Devices division (“Cosmo IMD”) is consolidating its strategy to accelerate the adoption of responsible and regulated AI in healthcare, obtaining pragmatic results in its...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2024
QGEN
LISTED
NYSE
QIAGEN erweitert QIAstat-Dx-Menü in den USA mit syndromischem Test für bessere Versorgung bei Magen-Darm-Erkrankungen
News Preview
QIAstat-Dx Gastrointestinal Panel 2 von der FDA in den USA zur klinischen Anwendung zugelassen // Neues Panel erkennt bis zu 16 gängige Erreger von Magen-Darm-Erkrankungen schnell und genau // Generiert Ergebnisse innerhalb rund einer Stunde, basierend auf Echtzeit-PCR-Technologie; ermöglicht einfachen Zugang zu Ct-Werten und Amplifikationskurven Q...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.06.2024
GMAB
LISTED
CPH
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.06.2024
GMAB
LISTED
CPH
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.06.2024
IMCR
LISTED
NASDAQ
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
News Preview
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response...
Themefolio
Profiler
Peergroup
© Newsfile
01.06.2024
COPN
LISTED
SIX
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024
News Preview
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - May 31, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its final audited results for the financial year 2023. Financial highlights As previously announced when publishing preliminar...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
IMCR
LISTED
NASDAQ
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024
News Preview
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
BAVA
LISTED
CPH
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
News Preview
COPENHAGEN, Denmark, May 31, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of a freeze-dried formulation of JYNNEOS® for prevention of smallpox and mpox disease in adults 18 years of age and older....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ZEAL
LISTED
CPH
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency
News Preview
Press release – No. 6 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
DBV
LISTED
EURONEXT
DBV Technologies Announces Plan to Implement ADS Ratio Change
News Preview
Châtillon, France, May 31, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ATAI
LISTED
NASDAQ
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
News Preview
NEW YORK and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the Company’s management team will participate in the Jefferies Global Healthcare Conference being held from Ju...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© EQS Newswire
31.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler Hosts Second Radionuclide Theranostics Forum in Boston, MA
News Preview
BOSTON, Mass., May 31, 2024 – Eckert & Ziegler reports about the successful completion of the 2nd annual Boston Radionuclide Theranostics Forum, reaffirming its pivotal role in the field of radiopharmaceuticals. Building on the momentum of last year's inaugural event, the Forum once again brought together leading experts, potential and existing......
Themefolio
Profiler
Peergroup
© EQS Newswire
31.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler veranstaltet zweites Radionuklid-Theranostik-Forum in Boston, MA
News Preview
BOSTON, Massachusetts, 31. Mai 2024 – Eckert & Ziegler freut sich über die erfolgreiche Durchführung des zweiten Boston Radionuclide Theranostics Forum, das seine zentrale Rolle im Bereich der Radiopharmazie erneut unter Beweis gestellt hat. Aufbauend auf der Dynamik der letztjährigen Eröffnungsveranstaltung brachte das Forum erneut führende Ex......
Themefolio
Profiler
Peergroup
© EQS Newswire
31.05.2024
EUZ
LISTED
XETR
Eckert & Ziegler veranstaltet zweites Radionuklid-Theranostik-Forum in Boston, MA
News Preview
BOSTON, Massachusetts, 31. Mai 2024 – Eckert & Ziegler freut sich über die erfolgreiche Durchführung des zweiten Boston Radionuclide Theranostics Forum, das seine zentrale Rolle im Bereich der Radiopharmazie erneut unter Beweis gestellt hat. Aufbauend auf der Dynamik der letztjährigen Eröffnungsveranstaltung brachte das Forum erneut führende Ex......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2024
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Provides Business and Corporate Update
News Preview
OSE Immunotherapeutics Provides Business and Corporate Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2024
CELC
LISTED
NASDAQ
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
News Preview
MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it plans to initiate a Phase 3 clinical trial to evaluate gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
News Preview
Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity
Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics
Lille University Hospital will provide human biological samp......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
News Preview
Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity
Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics
Lille University Hospital will provide human biological samp......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital und Inserm Transfert arbeiten zusammen, um neue therapeutische Ziele bei Adipositas und Stoffwechselerkrankungen zu identifizieren
News Preview
Partnerschaft wird Evotecs molekulare Patientendatenbank im Bereich Stoffwechselerkrankungen und insbesondere Adipositas erweitern
Evotec wird ihre führende PanOmics-Technologie für die Generierung von großen Omics-Datensätzen, einschließlich Transkriptomik, Proteomik und Metabolomik, einsetzen
Lille University Hospital wird biologi......
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
GNFT
LISTED
EURONEXT
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed its presence at the EASL Congress™ 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
RXRX
LISTED
NASDAQ
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
News Preview
Published open-access today in Nature Genetics, “High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing” identifies novel evidence of a proximity bias in CRISPR-Cas9 gene knockouts and a debiasing (correcting) algorithm. Published open-access today in Nature Genetics, “High-resolution genome-wide mapp...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
OSE
LISTED
EURONEXT
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024
News Preview
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ZEAL
LISTED
CPH
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
News Preview
Press release – No. 5 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B in the attach...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
POAI
LISTED
NASDAQ
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
News Preview
Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners through early oncologic drug discovery Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
IMCR
LISTED
NASDAQ
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
News Preview
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2024
MITRA
LISTED
EURONEXT
Mithra postpones its annual general meeting
News Preview
Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that in the context of the monetization process and the uncertainties related thereto, Mithra postpones its Annual General Shareholders’ Meeting, previously planned for 30 May 2024, to a later date to be determined. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2024
POAI
LISTED
NASDAQ
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
News Preview
Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
EVT
LISTED
XETR
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
News Preview
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease
One of Evotec’s largest strategic drug discovery alliances
Hamburg, Germany, 28 May 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
EVT
LISTED
XETR
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
News Preview
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease
One of Evotec’s largest strategic drug discovery alliances
Hamburg, Germany, 28 May 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
EVT
LISTED
XETR
Evotec und CHDI Foundation verlängern strategische Huntington-Allianz
News Preview
Langjährige Allianz zwischen Evotec und CHDI zur Entwicklung von Therapeutika für die Huntington-Krankheit
Eine der größten strategischen Wirkstoffforschungs-Allianzen von Evotec
Hamburg, 28. Mai 2024:
Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute die Verlängerung ihrer 20......
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2024
KDEV
LISTED
STO
Karolinska Development invests in BOOST Pharma, expanding its portfolio
News Preview
STOCKHOLM, SWEDEN – May 28, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the company has invested in BOOST Pharma – a company based on research from Karolinska Institutet that develops a first-in-class and potentially groundbreaking cell-based treatment of the rare bone disease osteogenesis imperfecta, also known as...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.05.2024
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2024
GXI
LISTED
XETR
Gerresheimer baut Kapazitäten für Medical Systems in den USA aus
News Preview
Gerresheimer baut Kapazitäten für Medical Systems in den USA aus
Zweistufiger Ausbau des Standortes Peachtree City, Georgia
Gesamtinvestitionsvolumen von rund 180 Mio. USD
Über 400 neue Arbeitsplätze für Fachkräfte aus der Region
Produktionsstart ab Ende 2024
Düsseldorf / Peachtree City, USA, 27. Mai 2024. Gerresheimer, innovativer System- und ......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2024
GXI
LISTED
XETR
Gerresheimer expands capacities for Medical Systems in the USA
News Preview
Gerresheimer expands capacities for Medical Systems in the USA
Two-stage expansion of the Peachtree City, Georgia site
Total investment volume of around USD 180 million
More than 400 new jobs for skilled workers from the region
Ramp-up of production beginning end of 2024
Düsseldorf / Peachtree City, USA, May 27, 2024 – Gerresheimer, an innovati......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
